ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,152Medicare Part D Prescriptions Filled, Including Refills

Rank: 64 out of 978

$548K Total Retail Price of All Prescriptions

Rank: 34 out of 978

316 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 316 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 6,632 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LEVOTHYROXINE SODIUM 312 266 1 4
WARFARIN SODIUM 242 191 2 11
HYDROCHLOROTHIAZIDE 233 190 3 5
CITALOPRAM HBR 206 181 4 14
LISINOPRIL 185 169 5 1
SIMVASTATIN 166 140 6 2
METOPROLOL TARTRATE 151 136 7 10
AMLODIPINE BESYLATE 148 128 8 6
METOPROLOL SUCCINATE 147 119 9 13
GABAPENTIN 147 96 9 15
NAMENDA 147 147 9 45
FUROSEMIDE 146 141 12 9
CRESTOR 138 101 13 30
OMEPRAZOLE 126 92 14 3
MIRTAZAPINE 123 123 15 31
SERTRALINE HCL 121 113 16 21
METFORMIN HCL 120 94 17 7
TRAZODONE HCL 117 71 18 18
PREDNISONE 114 114 19 47
DONEPEZIL HCL 111 111 20 26
FLUOXETINE HCL 105 64 21 42
KETOCONAZOLE 105 98 21 233
ATENOLOL 88 84 23 8
ADVAIR DISKUS 80 72 24 35
GALANTAMINE HBR 78 78 25 149
PROAIR HFA 66 37 26 19
POLYETHYLENE GLYCOL 3350 65 63 27 58
CYMBALTA 64 63 28 60
RISPERIDONE 61 49 29 49
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 47 29 36
NYSTOP 60 47 31 118
GLIPIZIDE 60 49 31 50
LOSARTAN POTASSIUM 59 56 33 22
VERAPAMIL ER 58 41 34 88
ATORVASTATIN CALCIUM 58 53 34 12
AGGRENOX 56 56 36 257
METHENAMINE HIPPURATE 56 56 36 323
SPIRONOLACTONE 56 49 36 87
DIOVAN 54 54 39 43
AMIODARONE HCL 53 53 40 185
RANITIDINE HCL 53 40 40 27
IPRATROPIUM-ALBUTEROL 52 52 42 101
ALENDRONATE SODIUM 50 42 43 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.